Legends Business Group (PINK:LGBS) reached up 72.97% in morning trading to $.0064 with 13M shares traded. Legends Business Group, Inc. was incorporated in March 2006.Currently the company’s newly launched division, Legends Power, has focused its mission to look for, test and acquire alternative and exotic energy products and technology and bring them into the marketplace. Legends Business Group (LGBS:PK) Tuesday announce that it has retained Patrick Rodgers, CPA, PA based in Florida, as its' auditor. "Legends is proud to have taken its first step to become a fully reporting Bulletin Board Company by retaining Patrick Rodgers, CPA, PA to perform the upcoming audit required to meet any reporting needs with the Securities and Exchange Commission ("SEC")," said Rudy Sablon, LGBS's President and CEO.
Infrastructure Developments Corp. (OTCBB:IDVC) reached up 38.89% in morning trading to $.0025 with 7M shares traded. Infrastructure Developments Corporation conducts its business through our subsidiary Interspec International, which is headquartered in the United States and focuses on project management in the Middle East, East Asia, and Oceania. Interspec fills an underserved niche in the global project spectrum, targeting specialized projects and subcontracts that are too small to attract the attention of the giant multinational firms but which still require world class engineering expertise. Interspec’s managers have decades of engineering experience, not only in the boardroom but in the hands-on world of managing complex engineering enterprises in difficult political environments and high-threat situations. Infrastructure Developments Corp. (IDVC) announced today that the Company pre-paid in full an outstanding $19,000 convertible note.
Genetic Technologies Limited (Nasdaq:GENE) reached up 16.74% in morning trading to $4.086 with 900K shares traded. Genetic Technologies is an established diagnostics company with more than 20 years of experience in commercializing genetic testing, non-coding DNA and product patenting. Genetic Technologies is focused on the commercialization of its patent portfolio through an active out-licensing program and the global expansion of its oncology and cancer management diagnostics assets. Its U.S. subsidiary, Phenogen Sciences, offers novel predictive testing and assessment tools to help physicians proactively manage women's health. Phenogen's lead product, BREVAGen™, is a first in class, clinically validated risk assessment test for non-familial breast cancer. Genetic Technologies Limited (GENE) announced that the Laboratory Field Services Unit of the California Department of Public Health (CDPH) has granted a license to the Company's Australian-based laboratory. BREVAGen™ may now be offered for sale into the State of California.
For a detailed quote on any of the following companies, or to read the full news articles visit PennyTrader.com
PennyTrader.com is a financial and investor relations website committed to covering the microcap market space including Pink Sheets and OTC Bulletin Board and sub-$5 big board stocks. We strive to provide you with the best stocks alerts in the market! We focus on OTCBB, OTC, penny stocks, sub-$5 big board stocks, and timely stocks picks and alerts. Our goal is to inform you of the HOTTEST stocks in the market before they move. Our staff has years experience in the stock market, and we are confident that you’ll be impressed with the results of our stock picks! If you wish to feature your organization on our website then you can contact us at email@example.com.
Disclosure: PennyTrader.com is not currently being compensated for any stocks covered in this midday report.
PennyTrader.com is not a registered investment advisers or broker/dealer. PennyTrader.com makes no recommendation that the purchase of securities of companies profiled in this press release is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the micro cap companies covered and the potential lack of an active trading market their securities, investing in such securities is highly speculative and carries a high degree of risk. For our full disclaimer go to CLICK HERE